Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients (Preedom)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00768196|
Recruitment Status : Completed
First Posted : October 7, 2008
Last Update Posted : December 7, 2010
|Condition or disease|
|Gastroesophageal Reflux Disease|
|Study Type :||Observational|
|Estimated Enrollment :||2000 participants|
|Official Title:||Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients|
|Study Start Date :||September 2008|
|Actual Study Completion Date :||February 2009|
- The primary variable is the total rate of GERD patients who had EED symptom and effect on their quality of life.
- The secondary variable is the comparison of the EED symptom frequency in ERD and NERD patients.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00768196
|Korea, Republic of|
|Cheonan, Chungnam, Korea, Republic of|
|Seoul, Kyungkido, Korea, Republic of|
|Sungnam, Kyungkido, Korea, Republic of|
|Suwon, Kyungkido, Korea, Republic of|
|Study Director:||Joon-Woo Bahn||AstraZeneca Korea|